
FDA, EMA and Good Machine Learning Practice: Why Drug Development Needs the Validated Action
The FDA and EMA are converging on a single demand for AI in drug development: every consequential action must be validated, attributable and reproducible. Mickai answers that demand at the substrate,
Jun 21, 20265 min read0 reactions0 comments